In the present study, we re-analysed the immune-related gene expression from the sample described in [32], but grouped the participants according to clinically-relevant cut-offs of serum CRP (<1, 1–3 and >3 mg/L), and compared CRP-based MDD groups between themselves and healthy controls. This evidence concerns the gene CRP and major depressive disorder.